Skip to main content
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC — Investor Relations & Filings

Ticker · OCTHF ISIN · GB00BMVMRB86 LEI · 2138005SRWT4998BCE35 IL Manufacturing
Open in API
Filings indexed 176 across all filing types
Latest filing 2024-01-30 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL OCTHF

About OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

https://www.oxcantech.com/

Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.

Recent filings

Filing Released Lang Actions
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim results' announcement for the six months ended 31 October 2023. It contains detailed operational highlights, financial highlights, a CEO's interim management statement, and a breakdown of drug development programs. Because it provides comprehensive financial and operational data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2023
2024-01-30 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number : 5175A) on January 23, 2024. The title is "Notice of Results & Analyst and Investor Presentations". The text explicitly states the company "intends to announce its results for the six-month period ended 31 October 2023, on Tuesday 30 January 2024" and details the schedule for an Analyst Briefing and an Investor Presentation related to those upcoming results. Since this document is an announcement about the *timing* and *format* of future report releases and investor engagement events, rather than the report itself (which would be an IR or ER), it fits the definition of a Report Publication Announcement (RPA). The document is short and serves to inform the market about the publication schedule.
2024-01-23 English
Patent Applications
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange.' It announces a specific corporate event: the filing of a European patent application related to Programme 2 targeting Trigeminal Neuralgia. This is a specific, material announcement made through an official regulatory news service. Since it is a specific announcement that doesn't fit into categories like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), and it is clearly a regulatory news service dissemination, the most appropriate classification is Regulatory Filings (RNS). The document length (5552 chars) is substantial enough that it is the primary announcement itself, not just a brief notice pointing to an attachment (which would suggest RPA).
2024-01-10 English
Directorate Appointment
Board/Management Information Classification · 98% confidence The document is identified by the RNS Number header and the explicit mention of 'RNS Number : 2956T' and 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates a regulatory news service announcement. The core content announces the appointment of Dr. Tim Corn as an executive director, which falls under changes in senior management or the board of directors. This aligns perfectly with the 'Board/Management Information' definition (Code: MANG). Although it is an RNS announcement, MANG is a more specific classification than the general RNS fallback.
2023-11-14 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is filed under RNS Number 0212R on October 24, 2023. The content explicitly details an 'acquisition or disposal of voting rights' by an individual (Anthony J Marshall) and an associated entity (Priory Woodfield Limited), resulting in a change in their percentage of voting rights (crossing the 3% threshold, as indicated by the resulting position of 3.11%). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general announcement (RNS), but a specific regulatory disclosure regarding ownership thresholds.
2023-10-24 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Specifically, it details an 'acquisition or disposal of voting rights' by 'Kingsley Capital Partners LLP' and the resulting holding percentage (14.95%), which crossed a notification threshold. This type of filing, related to significant changes in share ownership, corresponds directly to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS (RNS Number: 7354Q), the content itself is a specific regulatory disclosure form (TR-1) about major holdings, making MRQ the most precise classification over the general RNS fallback.
2023-10-20 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.